Neuroendocrine tumours trials in Norway

3 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

  Where

  Oslo

  Age

  12 years and over

  People

  355 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT04924075 · EU 2023-504853-11-00
• Phase 3Taking people
  DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

  Where

  Bergen, Oslo, Stavanger, Trondheim

  Age

  18 years and over

  People

  390 worldwide

  Run by

  Boehringer Ingelheim

  See details and how to joinNCT07544654 · EU 2025-523869-22-00
• No phaseTaking people
  Endoscopic Ultrasound Guided Radio Frequency Ablation of Pancreatic Neuroendocrine Neoplasms

  Where

  Oslo

  Age

  18 years and over

  People

  20

  Run by

  Oslo University Hospital

  See details and how to joinNCT05243082